thiamet-G [Ligand Id: 10509] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL1213603 (Thiamet-G) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| Beta-hexosaminidase subunit beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5877] [UniProtKB: P07686] | ||||||||
| ChEMBL | Inhibition of human beta hexosaminidase assessed as inhibitory constant using 4-methylumbelliferyl N-acetyl-beta-D-glucosaminide dihydrate as substrate measured every 60 sec for 45 mins by fluorescence spectrophotometry | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (2019) 62: 10062-10097 [PMID:31487175] |
| O-GlcNAcase/Bifunctional protein NCOAT in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5921] [GtoPdb: 3101] [UniProtKB: O60502] | ||||||||
| ChEMBL | Competitive inhibition of human O-GlcNAcase using 4-Np-GlcNAc as substrate after 5 mins by Dixon plot analysis | B | 7.68 | pKi | 21 | nM | Ki | Eur J Med Chem (2017) 139: 153-167 [PMID:28800454] |
| ChEMBL | Inhibition of recombinant human O-GlcNAcase using pNP-GlcNAc as substrate measured for 5 mins by UV-VIS spectrophotometer | B | 7.68 | pKi | 21 | nM | Ki | J Med Chem (2018) 61: 3239-3252 [PMID:28505447] |
| ChEMBL | Inhibition of human O-GlcNAcase | B | 7.68 | pKi | 21 | nM | Ki | Nat Chem Biol (2008) 4: 483-490 [PMID:18587388] |
| ChEMBL | Inhibition of human OGA | B | 7.68 | pKi | 21 | nM | Ki | Bioorg Med Chem Lett (2019) 29: 802-805 [PMID:30713024] |
| GtoPdb | - | - | 7.68 | pKi | 21 | nM | Ki | Nat Chem Biol (2008) 4: 483-90 [PMID:18587388] |
| ChEMBL | Inhibition of recombinant human OGA expressed in Escherichia coli assessed as inhibitory constant using 4-MUGlcNAc as substrate incubated for 20 mins by fluorescence based assay | B | 8.68 | pKi | 2.1 | nM | Ki | J Med Chem (2019) 62: 10062-10097 [PMID:31487175] |
| ChEMBL | Inhibition of recombinant human OGA | B | 9.39 | pKi | 0.41 | nM | Ki | J Med Chem (2019) 62: 10062-10097 [PMID:31487175] |
| ChEMBL | null: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acetyl-β-D-glucosaminide dihydrate (Sigma M2133) dissolved in ddH2O, as a substrate. The amount of purified human O-GlcNAcase enzyme used in the reaction was 0.7 nM. Test compound of varying concentrations was added to the enzyme prior to initiation of the reaction. The reaction was performed at room temperature in a 96-well plate and was initiated with the addition of substrate. The production of fluorescent product was measured every 60 sec for 45 min with a Tecan Infinite M200 plate-reader with excitation at 355 nM and emission detected at 460 nM, with 4-Methylumbelliferone (Sigma M1381) used to produce a standard curve. | B | 9.4 | pKi | 0.4 | nM | Ki | US-9243020-B2. Selective glycosidase inhibitors and uses thereof (2016) |
| ChEMBL | Inhibition of human O-GlcNAcase | B | 9.39 | pIC50 | 0.41 | nM | IC50 | J Med Chem (2019) 62: 10059-10061 [PMID:31668062] |
| ChEMBL | Inhibition of OGA (unknown origin) by cell based assay | B | 7.68 | pEC50 | 21 | nM | EC50 | J Med Chem (2019) 62: 10062-10097 [PMID:31487175] |
| ChEMBL | Cell-based ELISA Assay: The ELISA portion of the assay was performed in a black Maxisorp 96-well plate that was coated overnight at 4° C. with 100 uL/well of the cell lysate (1:10 dilution of the lysate with PBS containing protease inhibitors, phosphatase inhibitors, and PMSF). The following day the wells were washed 3 times with 300 uL/well of Wash buffer (Tris-buffered saline with 0.1% Tween 20). The wells were blocked with 100 ul/well Blocking buffer (Tris buffered saline w/0.05% Tween 20 and 2.5% Bovine serum albumin). Each well was then washed two times with 300 uL/well of wash buffer. The anti O-GlcNAc antibody RL-2 (Abeam, Cambridge, Mass.), diluted 1:1000 in blocking buffer, was added at 100 uL/well. The plate was sealed and incubated at 37° C. for 2 h with gentle shaking. The wells were then washed 3-times with 300 uL/well wash buffer. To detect the amount of RL-2 bound horse-radish peroxidase (HRP) conjugated goat anti-mouse secondary antibody (diluted 1:3000 in blocking buffer) was added at100 uL/well. The plate was incubated for 60 min at 37° C. with gentle shaking. Each well was then washed 3-times with 300 uL/well wash buffer. The detection reagent was added, 100 uL/well of Amplex Ultra RED reagent (prepared by adding 30 uL of 10 mM Amplex Ultra Red stock solution to 10 mL PBS with 18 uL 3% hydrogen peroxide, H2O2). The detection reaction was incubated for 15 minutes at room temperature and then read with excitation at 530 nm and emission at 590 nm. | B | 7.89 | pEC50 | 13 | nM | EC50 | US-9243020-B2. Selective glycosidase inhibitors and uses thereof (2016) |
| Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
| ChEMBL | Displacement of MK-0499 from human ERG | B | 4.52 | pIC50 | >30000 | nM | IC50 | J Med Chem (2019) 62: 10062-10097 [PMID:31487175] |
| Pregnane X receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3401] [GtoPdb: 606] [UniProtKB: O75469] | ||||||||
| ChEMBL | Activation of PXR (unknown origin) assessed as CYP3A4 induction | B | 4.52 | pEC50 | >30000 | nM | EC50 | J Med Chem (2019) 62: 10062-10097 [PMID:31487175] |
| O-GlcNAcase in Human [GtoPdb: 3101] [UniProtKB: O60502] | ||||||||
| GtoPdb | - | - | 7.68 | pKi | 21 | nM | Ki | Nat Chem Biol (2008) 4: 483-90 [PMID:18587388] |
| O-GlcNAcase/Protein O-GlcNAcase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3351213] [GtoPdb: 3101] [UniProtKB: Q8VIJ5] | ||||||||
| ChEMBL | Inhibition of O-GlcNAcase in rat PC12 cells assessed as induction of OGlcNAcylation after 24 hrs by Western blot method | B | 7.52 | pEC50 | 30 | nM | EC50 | J Med Chem (2018) 61: 3239-3252 [PMID:28505447] |
| ChEMBL | Inhibition of OGA in rat PC12 cells assessed as OGlcNAcylated protein level incubated for 24 hrs by ELISA | B | 7.87 | pEC50 | 13.5 | nM | EC50 | J Med Chem (2019) 62: 10062-10097 [PMID:31487175] |
| Nav1.5/Sodium channel protein type V alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1980] [GtoPdb: 582] [UniProtKB: Q14524] | ||||||||
| ChEMBL | Inhibition of Nav1.5 (unknown origin) | B | 4.52 | pIC50 | >30000 | nM | IC50 | J Med Chem (2019) 62: 10062-10097 [PMID:31487175] |
| Cav1.2/Voltage-gated L-type calcium channel alpha-1C subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1940] [GtoPdb: 529] [UniProtKB: Q13936] | ||||||||
| ChEMBL | Inhibition of Cav1.2 (unknown origin) | B | 4.52 | pIC50 | >30000 | nM | IC50 | J Med Chem (2019) 62: 10062-10097 [PMID:31487175] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
